[go: up one dir, main page]

CO6260091A2 - Derivados de iminopiridina y su uso - Google Patents

Derivados de iminopiridina y su uso

Info

Publication number
CO6260091A2
CO6260091A2 CO10145079A CO10145079A CO6260091A2 CO 6260091 A2 CO6260091 A2 CO 6260091A2 CO 10145079 A CO10145079 A CO 10145079A CO 10145079 A CO10145079 A CO 10145079A CO 6260091 A2 CO6260091 A2 CO 6260091A2
Authority
CO
Colombia
Prior art keywords
iminopiridine
derivatives
present
iminopyridine
prophylaxis
Prior art date
Application number
CO10145079A
Other languages
English (en)
Inventor
Masato Yoshida
Ayumu Sato
Nabuki Sakauchi
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of CO6260091A2 publication Critical patent/CO6260091A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

La presente invención pretende proporcionar un derivado de compuesto de iminopiridina que tiene una acción antagonista del receptor adrenérgico α1D, que es útil como un agente para la profilaxis o el tratamiento de una enfermedad del tracto urinario inferior y similares. La presente invención provee un compuesto representado por la fórmula en el cual cada símbolo es como se define en la memoria descriptiva, o una de sus sales.
CO10145079A 2008-04-23 2010-11-19 Derivados de iminopiridina y su uso CO6260091A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008113135 2008-04-23

Publications (1)

Publication Number Publication Date
CO6260091A2 true CO6260091A2 (es) 2011-03-22

Family

ID=40821652

Family Applications (1)

Application Number Title Priority Date Filing Date
CO10145079A CO6260091A2 (es) 2008-04-23 2010-11-19 Derivados de iminopiridina y su uso

Country Status (24)

Country Link
US (2) US20110039846A1 (es)
EP (1) EP2271624B9 (es)
JP (1) JP5462803B2 (es)
KR (1) KR20100130235A (es)
CN (1) CN102066327B (es)
AR (1) AR071392A1 (es)
AU (1) AU2009238938A1 (es)
BR (1) BRPI0910737A2 (es)
CA (1) CA2723216C (es)
CL (1) CL2009000964A1 (es)
CO (1) CO6260091A2 (es)
CR (1) CR11765A (es)
DO (1) DOP2010000321A (es)
EA (1) EA019641B1 (es)
EC (1) ECSP10010626A (es)
ES (1) ES2478823T3 (es)
GE (1) GEP20135883B (es)
IL (1) IL208771A0 (es)
MX (1) MX2010011652A (es)
NZ (1) NZ588909A (es)
PE (1) PE20091784A1 (es)
TW (1) TW200948784A (es)
UY (1) UY31781A (es)
WO (1) WO2009131245A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8470859B2 (en) 2006-10-23 2013-06-25 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
US20110039892A1 (en) * 2008-04-23 2011-02-17 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
US8481569B2 (en) 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
JP5462803B2 (ja) * 2008-04-23 2014-04-02 武田薬品工業株式会社 イミノピリジン誘導体およびその用途
TW201348187A (zh) 2012-04-24 2013-12-01 Chugai Pharmaceutical Co Ltd 苯甲醯胺衍生物
WO2013161853A1 (ja) 2012-04-24 2013-10-31 中外製薬株式会社 キナゾリンジオン誘導体
CN103058913B (zh) * 2012-12-13 2015-09-30 江苏弘和药物研发有限公司 5-氯异吲哚酮的合成方法
TW201605805A (zh) 2013-10-23 2016-02-16 Chugai Pharmaceutical Co Ltd 喹唑啉酮及異喹啉酮衍生物
PT3150581T (pt) * 2014-05-28 2020-05-19 Kotobuki Pharmaceutical Co Ltd Derivado de piridina
CN111217731B (zh) * 2020-02-19 2022-06-03 广东工业大学 一种邻位亚胺酯或氰基取代的芳基硫醚衍生物及制备与应用
CN115703722B (zh) * 2021-08-03 2024-06-25 江苏国泰超威新材料有限公司 一种n,n-二甲基三氟甲基磺酰胺的制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2540109B1 (fr) * 1983-01-28 1985-08-30 Logeais Labor Jacques Imino-2 pyrrolidines, leur procede de preparation et leurs applications en therapeutique
DE4021439A1 (de) * 1989-12-14 1991-06-20 Bayer Ag 2-iminopyridin-derivate
US5688795A (en) * 1994-11-08 1997-11-18 Syntex (U.S.A.) Inc. 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
UA52681C2 (uk) * 1997-04-08 2003-01-15 Янссен Фармацевтика Н.В. Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі
ZA991315B (en) * 1998-02-20 2000-11-20 Ortho Mcneil Pharm Inc Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia.
US6153614A (en) * 1998-07-16 2000-11-28 Abbott Laboratories Piperazinyl pyrimidine dione compounds selective for adrenoceptors
DE19845202A1 (de) * 1998-10-01 2000-04-06 Wella Ag Haarwuchsmittel
EP1415987B1 (en) * 2000-10-20 2007-02-28 Eisai R&D Management Co., Ltd. Nitrogenous aromatic ring compounds as anti cancer agents
FR2825705B1 (fr) * 2001-06-08 2005-05-20 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
US7375100B2 (en) * 2003-06-04 2008-05-20 Pfizer Inc 2-amino-pyridine derivatives useful for the treatment of diseases
PL1730103T3 (pl) * 2004-03-23 2010-10-29 Pfizer Pochodne formamidu użyteczne jako adrenoreceptor
ES2241496B1 (es) * 2004-04-15 2006-12-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridina.
US20050288270A1 (en) * 2004-05-27 2005-12-29 Pfizer Inc New aminopyridine derivatives and their use as pharmaceuticals
TW200700392A (en) * 2005-03-16 2007-01-01 Astrazeneca Ab Novel compounds
ES2303758B1 (es) * 2006-02-20 2009-08-13 Laboratorios Almirall S.A. Nuevos derivados de piridin-3-amina.
US8470859B2 (en) * 2006-10-23 2013-06-25 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
US8293747B2 (en) * 2007-07-19 2012-10-23 Merck Sharp & Dohme Corp. Heterocyclic amide compounds as protein kinase inhibitors
MX2010010317A (es) * 2008-03-21 2010-10-04 Novartis Ag Compuestos heterociclicos novedosos y usos de los mismos.
JP5462803B2 (ja) * 2008-04-23 2014-04-02 武田薬品工業株式会社 イミノピリジン誘導体およびその用途
US8290250B2 (en) * 2008-12-26 2012-10-16 Five Apes, Inc. Method and apparatus for creating a pattern recognizer

Also Published As

Publication number Publication date
JP2011518766A (ja) 2011-06-30
BRPI0910737A2 (pt) 2019-09-24
UY31781A (es) 2009-12-14
EP2271624A1 (en) 2011-01-12
NZ588909A (en) 2012-08-31
JP5462803B2 (ja) 2014-04-02
EA201071229A1 (ru) 2011-06-30
EA019641B1 (ru) 2014-05-30
CN102066327B (zh) 2013-05-29
ES2478823T3 (es) 2014-07-23
ECSP10010626A (es) 2011-03-31
EP2271624B1 (en) 2014-05-21
CA2723216C (en) 2017-01-24
CL2009000964A1 (es) 2010-03-26
TW200948784A (en) 2009-12-01
AU2009238938A1 (en) 2009-10-29
PE20091784A1 (es) 2009-12-05
KR20100130235A (ko) 2010-12-10
DOP2010000321A (es) 2010-11-15
GEP20135883B (en) 2013-07-25
EP2271624B9 (en) 2014-11-12
CA2723216A1 (en) 2009-10-29
WO2009131245A1 (en) 2009-10-29
CR11765A (es) 2010-12-15
MX2010011652A (es) 2010-12-06
US20090270393A1 (en) 2009-10-29
AR071392A1 (es) 2010-06-16
CN102066327A (zh) 2011-05-18
US20110039846A1 (en) 2011-02-17
IL208771A0 (en) 2010-12-30

Similar Documents

Publication Publication Date Title
CO6260091A2 (es) Derivados de iminopiridina y su uso
ECSP13012478A (es) Compuesto heterocíclico y su uso
UY32923A (es) Compuestos policíclicos como antagonistas del receptor de ácido lisofosfatídico
ECSP12011573A (es) Compuestos tetracíclicos
ECSP14013329A (es) Compuestos de arylcarbonil-4-oxy-piperidina utilizados para el tratamiento de enfermedades neurodegenerativas
ECSP13012719A (es) Compuesto bicíclico
CL2016000341A1 (es) Métodos para tratar la miositis por cuerpos de inclusión esporádica
CR20120448A (es) Compuesto heterocíclico
ECSP10010025A (es) Derivados de isoquinolinilo e isoindolinilo como antagonistas de la histamina-3
NI201000035A (es) Derivados de azaciclilisoquinolinona e isoindolinona como antagonistas de histamina-3
CO6341625A2 (es) Derivados de indol como agentes anticáncer
CL2015002434A1 (es) Moduladores benzoimidazol-2-il pirimidinas del receptor h4 de histamina.
CO6491037A2 (es) Derivados de pirazinooxazepina
CL2017000069A1 (es) Derivado de hidantoina.
UY32408A (es) Macrolido anti-inflamatorio
CR20150148A (es) Azaindolinas
PA8814801A1 (es) Triazolopiridazinas como inhibidores de par1, su preparación y su uso como medicamentos
UY32042A (es) Compuestos de 2-aminopirimidina como potentes inhibidores de hsp-90
ECSP10010625A (es) Derivados de iminopiridina y uso de los mismos
CU20110020A7 (es) Compuestos de fenantrenona, composiciones y métodos
UY32191A (es) Derivados de iminopiridina y uso de los mismos
ECSP088789A (es) Derivados de sulfonil-3-heterociclilindazol como ligandos de 5-hidroxitriptamina-6
UY32088A (es) Compuesto heterociclico
UY36350A (es) Compuesto derivado de pirazol para tratamiento o prevención de la enfermedad de chagas.
CU20100047A7 (es) Derivados de azaciclilisoquinolinona e-isoindolinona como antagonistas de la histamina-3

Legal Events

Date Code Title Description
FG Application granted